BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 28902345)

  • 1. Cx32 suppresses extrinsic apoptosis in human cervical cancer cells via the NF‑κB signalling pathway.
    Lai Y; Fan L; Zhao Y; Ge H; Feng X; Wang Q; Zhang X; Peng Y; Wang X; Tao L
    Int J Oncol; 2017 Oct; 51(4):1159-1168. PubMed ID: 28902345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cx32 inhibits TNFα-induced extrinsic apoptosis with and without EGFR suppression.
    Lai Y; Tao L; Zhao Y; Zhang X; Sun X; Wang Q; Xu C
    Oncol Rep; 2017 Nov; 38(5):2885-2892. PubMed ID: 28901517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-junctional Cx32 mediates anti-apoptotic and pro-tumor effects via epidermal growth factor receptor in human cervical cancer cells.
    Zhao Y; Lai Y; Ge H; Guo Y; Feng X; Song J; Wang Q; Fan L; Peng Y; Cao M; Harris AL; Wang X; Tao L
    Cell Death Dis; 2017 May; 8(5):e2773. PubMed ID: 28492539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fucoxanthin and Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) Synergistically Promotes Apoptosis of Human Cervical Cancer Cells by Targeting PI3K/Akt/NF-κB Signaling Pathway.
    Jin Y; Qiu S; Shao N; Zheng J
    Med Sci Monit; 2018 Jan; 24():11-18. PubMed ID: 29291370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cx32 promotes autophagy and produces resistance to SN‑induced apoptosis via activation of AMPK signalling in cervical cancer.
    Fan LX; Tao L; Lai YC; Cai SY; Zhao ZY; Yang F; Su RY; Wang Q
    Int J Oncol; 2022 Jan; 60(1):. PubMed ID: 34970699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cx32 mediates cisplatin resistance in human ovarian cancer cells by affecting drug efflux transporter expression and activating the EGFR‑Akt pathway.
    Zhang Y; Tao L; Fan LX; Huang K; Luo HM; Ge H; Wang X; Wang Q
    Mol Med Rep; 2019 Mar; 19(3):2287-2296. PubMed ID: 30664215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Curcumin [1,7-bis(4-hydroxy-3-methoxyphenyl)-1-6-heptadine-3,5-dione; C21H20O6] sensitizes human prostate cancer cells to tumor necrosis factor-related apoptosis-inducing ligand/Apo2L-induced apoptosis by suppressing nuclear factor-kappaB via inhibition of the prosurvival Akt signaling pathway.
    Deeb D; Jiang H; Gao X; Al-Holou S; Danyluk AL; Dulchavsky SA; Gautam SC
    J Pharmacol Exp Ther; 2007 May; 321(2):616-25. PubMed ID: 17289836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-canonical NFκB mutations reinforce pro-survival TNF response in multiple myeloma through an autoregulatory RelB:p50 NFκB pathway.
    Roy P; Mukherjee T; Chatterjee B; Vijayaragavan B; Banoth B; Basak S
    Oncogene; 2017 Mar; 36(10):1417-1429. PubMed ID: 27641334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The anti-CD20 mAb LFB-R603 interrupts the dysregulated NF-κB/Snail/RKIP/PTEN resistance loop in B-NHL cells: role in sensitization to TRAIL apoptosis.
    Baritaki S; Militello L; Malaponte G; Spandidos DA; Salcedo M; Bonavida B
    Int J Oncol; 2011 Jun; 38(6):1683-94. PubMed ID: 21455568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cx32 exerts anti-apoptotic and pro-tumor effects via the epidermal growth factor receptor pathway in hepatocellular carcinoma.
    Xiang Y; Wang Q; Guo Y; Ge H; Fu Y; Wang X; Tao L
    J Exp Clin Cancer Res; 2019 Apr; 38(1):145. PubMed ID: 30947731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. STAT3 activity regulates sensitivity to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in cervical cancer cells.
    Nakamura H; Taguchi A; Kawana K; Kawata A; Yoshida M; Fujimoto A; Ogishima J; Sato M; Inoue T; Nishida H; Furuya H; Tomio K; Eguchi S; Mori-Uchino M; Yamashita A; Adachi K; Arimoto T; Wada-Hiraike O; Oda K; Nagamatsu T; Osuga Y; Fujii T
    Int J Oncol; 2016 Nov; 49(5):2155-2162. PubMed ID: 27599897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Artesunate enhances TRAIL-induced apoptosis in human cervical carcinoma cells through inhibition of the NF-κB and PI3K/Akt signaling pathways.
    Thanaketpaisarn O; Waiwut P; Sakurai H; Saiki I
    Int J Oncol; 2011 Jul; 39(1):279-85. PubMed ID: 21537836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PRMT5, a novel TRAIL receptor-binding protein, inhibits TRAIL-induced apoptosis via nuclear factor-kappaB activation.
    Tanaka H; Hoshikawa Y; Oh-hara T; Koike S; Naito M; Noda T; Arai H; Tsuruo T; Fujita N
    Mol Cancer Res; 2009 Apr; 7(4):557-69. PubMed ID: 19372584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-214 activates TP53 but suppresses the expression of RELA, CTNNB1, and STAT3 in human cervical and colorectal cancer cells.
    Chandrasekaran KS; Sathyanarayanan A; Karunagaran D
    Cell Biochem Funct; 2017 Oct; 35(7):464-471. PubMed ID: 29023799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Connexins and apoptotic transformation.
    Kalvelyte A; Imbrasaite A; Bukauskiene A; Verselis VK; Bukauskas FF
    Biochem Pharmacol; 2003 Oct; 66(8):1661-72. PubMed ID: 14555247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vanillin enhances TRAIL-induced apoptosis in cancer cells through inhibition of NF-kappaB activation.
    Lirdprapamongkol K; Sakurai H; Suzuki S; Koizumi K; Prangsaengtong O; Viriyaroj A; Ruchirawat S; Svasti J; Saiki I
    In Vivo; 2010; 24(4):501-6. PubMed ID: 20668316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of tumor necrosis factor alpha, TNF-related apoptosis-inducing ligand, and their associated molecules in ameloblastomas.
    Kumamoto H; Ooya K
    J Oral Pathol Med; 2005 May; 34(5):287-94. PubMed ID: 15817072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apigenin potentiates TRAIL therapy of non-small cell lung cancer via upregulating DR4/DR5 expression in a p53-dependent manner.
    Chen M; Wang X; Zha D; Cai F; Zhang W; He Y; Huang Q; Zhuang H; Hua ZC
    Sci Rep; 2016 Oct; 6():35468. PubMed ID: 27752089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apoptosis effects of Xrel3 c-Rel/Nuclear Factor-kappa B homolog in human cervical cancer cells.
    Shehata M; Shehata M; Shehata F; Pater A
    Cell Biol Int; 2005 Jun; 29(6):429-40. PubMed ID: 16054560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cl-IB-MECA enhances TRAIL-induced apoptosis via the modulation of NF-kappaB signalling pathway in thyroid cancer cells.
    Morello S; Sorrentino R; Porta A; Forte G; Popolo A; Petrella A; Pinto A
    J Cell Physiol; 2009 Nov; 221(2):378-86. PubMed ID: 19562684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.